Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

EU15 Anesthesia, Respiratory & Sleep Therapy Devices Market-COVID19-2021-2027-MedSuite-Includes: Anesthesia Devices (Disposables, Monitors, Delivery Units), Respiratory Devices & Sleep Management Devices

Published by iData Research Inc. Product code 1000936
Published Content info 588 Pages
Delivery time: 1-2 business days
Price
Back to Top
EU15 Anesthesia, Respiratory & Sleep Therapy Devices Market-COVID19-2021-2027-MedSuite-Includes: Anesthesia Devices (Disposables, Monitors, Delivery Units), Respiratory Devices & Sleep Management Devices
Published: March 26, 2021 Content info: 588 Pages
Description

Throughout this medical market research, the publisher analyzed 84+ Anesthesia, Respiratory and Sleep Management companies in Europe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this report suite report contains all of the EU15 Anesthesia, Respiratory and Sleep Management market analysis, each of the market segments is also available as a stand-alone a report, MedCore.

Markets Covered:

Anesthesia Monitors Market | Europe | 2021-2027 | MedCore

Anesthesia Delivery Unit (ADU) Devices Market | Europe | 2021-2027 | MedCore

Anesthesia Disposables Market | Europe | 2021-2027 | MedCore

Ventilator Market | Europe | 2021-2027 | MedCore

Nebulizer Market | Europe | 2021-2027 | MedCore

Oxygen Therapy Market | Europe | 2021-2027 | MedCore

Therapeutic Obstructive Sleep Apnea Device Market | Europe | 2021-2027 | MedCore

Sleep Diagnostic Devices Market | Europe | 2021-2027 | MedCore

Europe Anesthesia, Respiratory and Sleep Management Market Insights

Overall, the European market for anesthesia, respiratory and sleep management devices was valued at nearly €1.9 billion in 2020 and will decline slightly over the forecast period, due to the declining ASPs and market corrections post-COVID offsetting growth in unit sales, to €1.8 billion in 2027.

The ARS market demographic includes surgery patients and senior citizens. With the decline in global air quality, illnesses of the respiratory tract, such as chronic obstructive pulmonary disease (COPD), will increase in incidence. This growth will also affect the ARS market. As the awareness and the frequency of diagnoses, as well as self-diagnoses, increases, so will the population of individuals requiring some form of treatment from this market. In the short term, however, the market was negatively impacted by COVID-19 due to mass cancellations and postponements of surgeries across all countries.

In 2020, ResMed was the leading competitor in the anesthesia, respiratory and sleep management device market. The company led the therapeutic obstructive sleep apnea device market in Europe, with a notable presence in both the sleep therapy interface and PAP device segments. This segment is so large that it positioned ResMed as the overall market leader.

Back to Top